Unravelling the relationship between macroautophagy and mitochondrial ROS in cancer therapy

Yuqian Zhao1, Tiange Qu2, Peiqi Wang3

  • 1Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, China.

Insights

Reactive oxygen species (ROS) influence autophagy, a cellular process with dual roles in cancer. This study explores mitochondrial ROS (mitoROS) and autophagy

Area of Science:

  • Cell Biology
  • Cancer Biology
  • Biochemistry

Background:

  • Macroautophagy (autophagy) is a conserved cellular process activated by stimuli like oxidative stress.
  • Reactive oxygen species (ROS) modulate autophagy through various pathways, with complex roles in cancer.
  • Mitochondrial ROS (mitoROS) are key signaling molecules in autophagy regulation.

Purpose of the Study:

  • To elucidate the intricate relationship between mitochondrial ROS and autophagy.
  • To understand the dual role of ROS-modulated autophagy in cancer progression and suppression.
  • To identify novel anti-cancer drug targets by focusing on mitoROS-regulated autophagy.

Main Methods:

  • Literature review and synthesis of existing data on ROS, autophagy, and cancer.
  • Analysis of signaling pathways and transcription regulators involved in ROS-autophagy interaction.
  • Focus on anti-tumor agents targeting mitoROS-regulated autophagy.

Main Results:

  • ROS exhibit both tumor-suppressive (autophagic cell death, genome stability) and tumor-promoting (metabolic support) roles in cancer.
  • Autophagy regulates mitoROS generation, creating a feedback loop.
  • The interplay between mitoROS and autophagy determines whether autophagy acts protectively or detrimentally.

Conclusions:

  • Untangling the mitoROS-autophagy axis is crucial for understanding autophagy's dual role in cancer.
  • Targeting mitoROS-regulated autophagy offers potential for novel cancer therapies.
  • Further exploration of anti-tumor agents in this pathway may yield new anti-cancer drugs.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.5K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
17.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
5.0K